Chemicals · Founded 1993 · www.revatiorganics.in · BSE 524504 · · ISIN INE270D01015
No Notes Added Yet
Business
Assuming Revati Media Ltd. operates in the Chemicals sector as specified, its core business would involve the manufacturing, processing, and distribution of various chemical products. This could range from basic chemicals (commodities like acids, alkalis, petrochemicals) to specialty chemicals (additives, dyes, agrochemicals, pharmaceuticals intermediates) or performance chemicals. The company would generate revenue by selling these chemical products to other industries (e.g., textiles, agriculture, pharmaceuticals, automotive, construction) as raw materials, intermediates, or finished goods. Its business model would likely focus on production efficiency, supply chain management, R&D for new product development, and maintaining quality standards.
Revenue Mix
Without specific company data, the exact segments are unknown. However, a typical chemicals company in India might operate in segments such as:
Basic Chemicals: Large-volume commodity chemicals with relatively lower margins.
Specialty Chemicals: Higher-value products with specific applications, often requiring R&D and technical expertise, offering better margins.
Agrochemicals: Products for crop protection and nutrition.
Pharmaceutical Intermediates: Chemicals used in the production of drugs.
Polymers/Plastics: Production of various plastic materials.
The revenue mix would depend on the company's strategic focus, with specialty chemicals generally offering more stable and higher-margin revenue streams compared to volatile basic chemicals.
Industry
The Indian Chemicals industry is diverse and robust, comprising both large multinational corporations and numerous domestic players. It is a fundamental input industry for various other sectors. The industry structure includes highly fragmented segments (e.g., dyes, pigments) and consolidated segments (e.g., certain petrochemicals). Positioning for a company like Revati Media Ltd. would depend on its product portfolio:
Cost Leadership: For basic chemicals, focusing on scale and efficient production.
Niche Specialization: For specialty chemicals, focusing on specific applications or unique formulations.
Backward/Forward Integration: To control supply chain and add value.
The company would likely compete on price, product quality, delivery reliability, and technical support.
MOAT
For a chemicals company, potential competitive advantages (moats) could include:
Cost Efficiency/Scale: Achieving economies of scale in manufacturing, leading to lower per-unit costs, particularly in commodity chemicals.
R&D and Innovation: Developing proprietary processes or specialty products that are difficult for competitors to replicate.
Regulatory Barriers/Approvals: Obtaining specific certifications or approvals for certain chemicals can create entry barriers.
Customer Relationships & Switching Costs: For specialty chemicals, deep integration with customer processes can make switching suppliers difficult.
Backward Integration: Control over raw material sources can ensure supply stability and cost advantage.
Brand Reputation: While less common for industrial chemicals, consistent quality and reliability can build a strong reputation.
Growth Drivers
Key factors that can drive growth for a chemicals company in India over the next 3-5 years include:
Domestic Demand: Growing consumption in end-user industries like automotive, construction, textiles, agriculture, and pharmaceuticals due to India's economic growth and rising population.
"China Plus One" Strategy: Global manufacturers diversifying their supply chains away from China, leading to increased export opportunities for Indian chemical manufacturers.
Government Initiatives: Schemes like "Make in India" promoting domestic manufacturing and production-linked incentive (PLI) schemes in allied sectors benefiting chemical inputs.
Increasing Specialization: Shift towards higher-value specialty chemicals, which offer better margins and less commodity price volatility.
Import Substitution: Efforts to reduce reliance on chemical imports by boosting domestic production.
Risks
Key business risks for a chemicals company like Revati Media Ltd. would include:
Raw Material Price Volatility: Many chemical feedstocks are derivatives of crude oil or other commodities, making input costs susceptible to global price fluctuations.
Environmental & Regulatory Risks: Strict environmental protection regulations (e.g., pollution control, waste management) and safety standards can increase operational costs and compliance burdens.
Economic Slowdown: A downturn in end-user industries (e.g., automotive, construction) can significantly impact demand for chemicals.
Intense Competition: The presence of both domestic and international players can lead to pricing pressures and margin erosion.
Currency Fluctuations: Affects import costs of raw materials and export revenues.
Technological Obsolescence: Rapid advancements in chemical processes or new product development by competitors can render existing products or methods less competitive.
Management & Ownership
Without specific details, it is difficult to assess management quality. In India, many companies, especially mid-sized ones, are promoter-driven, meaning the founding family or individuals hold significant ownership and control. Key aspects for assessment would typically include:
Experience & Track Record: The management team's history in the chemicals sector and prior success.
Corporate Governance: Adherence to ethical practices and transparency.
Vision & Strategy: Their ability to articulate and execute a clear growth strategy.
Ownership Structure: Promoter holding percentage, institutional ownership, and public float, which can influence decision-making and market liquidity.
Outlook
The outlook for Revati Media Ltd., assuming it is a chemicals company, is influenced by the broad positive trends in the Indian chemicals sector.
Bull Case: Driven by robust domestic demand, the "China Plus One" strategy boosting exports, and potential for margin expansion through a shift towards specialty chemicals and efficient operations, the company could achieve steady revenue and profit growth. Strategic investments in R&D and capacity expansion, coupled with favorable government policies, could further enhance its market position and profitability.
Bear Case: The company faces significant risks from volatile raw material prices, intense competition, and stringent environmental regulations. A global economic slowdown or a sharp depreciation of the rupee could severely impact profitability. Lack of differentiation or an inability to innovate could lead to margin erosion and loss of market share in a competitive landscape. The company would need to navigate these challenges effectively to sustain growth.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Adjusted Earnings Per Share | -0.9 | -0.2 | -0.3 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.4 | -0.2 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Operating Profit | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Adjusted Earnings Per Share | -0 | -0 | -0.1 | -0.1 | -0 | 0.1 | 0 | 0.1 | -1.4 | -0.9 | -1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | -100% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 70% | NA% | NA% | NA% |
| ROE Average | -27% | -19% | -11% | -6% |
| ROCE Average | -11% | -8% | -5% | -3% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Fixed Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other Non-Current Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Total Current Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Total Assets | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -0 | -0 |
| Cash Flow from Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Financing Activities | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Inflow / Outflow | -0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | -0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0 | -0.01 | -0.05 | -0.12 | -0.01 | 0.09 | 0.01 | 0.07 | -1.4 | -0.93 |
| CEPS(Rs) | -0 | -0.01 | -0.05 | -0.12 | -0.01 | 0.09 | 0.01 | 0.07 | -1.4 | -0.93 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 5.3 | 5.29 | 5.24 | 5.12 | 5.12 | 5.21 | 5.21 | 5.28 | 3.89 | 2.96 |
| Core EBITDA Margin(%) | 0 | 0 | 0 | 0 | -139.33 | 4.58 | 0.32 | -10.5 | -644.38 | 0 |
| EBIT Margin(%) | 0 | 0 | 0 | 0 | 1.76 | 4.58 | 0.32 | 3.72 | -523.17 | 0 |
| Pre Tax Margin(%) | 0 | 0 | 0 | 0 | -3.59 | 4.57 | 0.29 | 3.7 | -523.4 | 0 |
| PAT Margin (%) | 0 | 0 | 0 | 0 | -3.59 | 4.57 | 0.29 | 3.64 | -523.4 | 0 |
| Cash Profit Margin (%) | 0 | 0 | 0 | 0 | -3.59 | 4.57 | 0.29 | 3.64 | -523.4 | 0 |
| ROA(%) | -0.02 | -0.11 | -0.5 | -1.16 | -0.06 | 0.87 | 0.05 | 0.65 | -14.32 | -10.42 |
| ROE(%) | -0.04 | -0.21 | -0.97 | -2.28 | -0.12 | 1.72 | 0.11 | 1.3 | -30.46 | -27.09 |
| ROCE(%) | -0.02 | -0.11 | -0.5 | -0.36 | 0.03 | 0.93 | 0.07 | 0.73 | -15.27 | -10.72 |
| Receivable days | 0 | 0 | 0 | 0 | 2231.11 | 316.4 | 323.93 | 208.89 | 956.83 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 14.06 | 0.03 | 0.03 | 0.03 | 0.2 | 0 |
| Payable days | 0 | 0 | 0 | 0 | 2224.03 | 194.14 | 333.23 | 223.57 | 926 | 0 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0 | 0 | 0 | 0 | 80.39 | 7.35 | 6.73 | 7.65 | 55.21 | 0 |
| EV/Core EBITDA(x) | -8245.21 | -1352.99 | -289.37 | -398.12 | 4561.4 | 160.59 | 2094.71 | 205.64 | -10.55 | -16.93 |
| Net Sales Growth(%) | 0 | 0 | 0 | 0 | 0 | 998.02 | 1.97 | -5.3 | -85.78 | -100 |
| EBIT Growth(%) | 45.32 | -508.08 | -366.38 | 28.66 | 108.55 | 2752.68 | -92.84 | 996.12 | -2100.16 | 33.6 |
| PAT Growth(%) | 77.33 | -490.45 | -363.21 | -130.65 | 94.61 | 1494.73 | -93.54 | 1093.19 | -2142.65 | 33.58 |
| EPS Growth(%) | 77.33 | -490.45 | -363.54 | -130.47 | 94.61 | 1493.96 | -93.57 | 1098.25 | -2143.48 | 33.58 |
| Debt/Equity(x) | 0.92 | 0.92 | 0.93 | 0.95 | 0.85 | 0.84 | 0.84 | 0.83 | 1.22 | 1.93 |
| Current Ratio(x) | 17.7 | 17.63 | 17.13 | 14.42 | 47.41 | 2.46 | 3.1 | 2.94 | 2.47 | 2.43 |
| Quick Ratio(x) | 17.62 | 17.55 | 17.04 | 14.35 | 47.4 | 2.46 | 3.1 | 3.04 | 2.9 | 3 |
| Interest Cover(x) | -26.38 | -127.93 | -1036.09 | -0.45 | 0.33 | 356.07 | 9.99 | 193.75 | -2214.46 | -2437.61 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | — | -100% | — | — |
| Operating Profit CAGR | — | — | — | — |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | +70% | — | — | — |
| ROE Average | -27% | -19% | -11% | -6% |
| ROCE Average | -11% | -8% | -5% | -3% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 | 33.65 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 | 66.35 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.